Company profile: Miacom Diagnostics
1.1 - Company Overview
Company description
- Provider of microbiological tools for pathogen identification, manufacturing laboratory equipment, medical devices, and electrosurgery machines.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Miacom Diagnostics
SaNOtize
HQ: Canada
Website
- Description: Provider of platform-based nitric oxide topical therapies for upper respiratory and dermal infections, including a Nitric Oxide Nasal Spray (NONS) that reduces respiratory viral RNA load within 24–72 hours, a physician-provided Foot Cleanser for plantar warts, and a Gel Cleanser for nails and skin in development, with additional cleansers and wellness products planned for US launch in 2025–2026.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SaNOtize company profile →
NanoView Biosciences
HQ: United States
Website
- Description: Provider of proprietary products supporting research, translation and delivery of precision medicine, built on a novel platform that uniquely identifies and characterizes exosomes. Offers high-throughput, cost-effective analysis, including Leprechaun for lentivirus and exosome biophysical characterization, contaminant detection, and concentration measurement using fluorescence and antibody-based methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoView Biosciences company profile →
Artus Biotech
HQ: Germany
Website
- Description: Provider of DNA-based diagnostic kits focused on PCR and real-time PCR, developed, produced, and sold for detection of infectious agents and use in pharmacogenomics and veterinary applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artus Biotech company profile →
Destiny Pharma
HQ: United Kingdom
Website
- Description: Provider of novel antimicrobial products in clinical development, including XF-73 Nasal for prevention of post-surgical Staphylococcal infections (preparing for Phase 3), NTCD-M3 to prevent recurring C. difficile gut infections (preparing for Phase 3), XF-73 Dermal for skin infections, an XF platform with a rapid mechanism that reduces resistance, and biotherapeutic programs for infection prevention.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Destiny Pharma company profile →
AN2 Therapeutics
HQ: United States
Website
- Description: Provider of boron chemistry–based drug discovery and clinical development for infectious diseases, including epetraborole, an oral therapy in development for chronic non-tuberculous mycobacterial lung disease targeting Mycobacterium avium complex, and conducting clinical trials to obtain regulatory approval for new medications for infectious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AN2 Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Miacom Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Miacom Diagnostics
2.2 - Growth funds investing in similar companies to Miacom Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Miacom Diagnostics
4.2 - Public trading comparable groups for Miacom Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →